A Study to Evaluate the Long-Term Safety and Efficacy of HSK39297 Tablets in Primary IgA Nephropathy
Clinical trial NCT07616700 · RECRUITING
Trial details
- NCT number
- NCT07616700
- Sponsor
- Haisco Pharmaceutical Group Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-08-25
- Primary completion
- 2026-12-05
- Enrollment
- 73
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.